Table 1.
Downstaging and bridging protocol
| Downstaging and bridging protocol | |
| Inclusion Criteria | |
| Bridging | |
| Patients who were within MC or UNOS T2 | |
| Downstaging subgroups (HCC exceeding MC) | |
| Group 1 = 1 lesion > 5 and ≤ 8 cm | |
| Group 2 = 2 or 3 lesions at least one > 3 and ≤ 5 cm with the sum of the maximal tumor diameters ≤ 8 cm | |
| Group 3 = 4 or 5 lesions each ≤ 3 cm with the sum of the maximal tumor diameters ≤ 8 cm | |
| Group 4 = 2 or 3 lesions at least one > 5cm with the sum of the maximal tumor diameters ≤ 8 cm | |
| Group 5 = total tumor diameter > 8 cm | |
| Absence of vascular invasion based on cross-sectional MRI or CT | |
| Criteria for successful downstaging | |
| Residual tumor(s) within MC for deceased donor liver transplant | |
| In patients with 4 or 5 tumors, successful downstaging requires complete necrosis (based on cross-sectional MRI or CT) of at least 1 to 2 tumor(s), respectively, so that there will be no more than 3 lesions with viable tumor each ≤ 3 cm to meet MC | |
| Criteria for downstaging failure and exclusion from liver transplant | |
| Progression of tumor(s) to beyond inclusion criteria for downstaging and bridging based on tumor size and number | |
| Vascular invasion based on cross-sectional MRI or CT | |
| Lymph node involvement by tumor or extra-hepatic spread of tumor | |
MC: Milan criteria; UNOS: United Network for Organs Sharing; HCC: Hepatocellular carcinoma; MRI: Magnetic resonance imaging; CT: Computed tomography.